Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.

MLA

Ostronoff, Fabiana, et al. “Fludarabine, Cyclophosphamide, and Antithymocyte Globulin for a Patient with Dyskeratosis Congenita and Severe Bone Marrow Failure.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 13, no. 3, Mar. 2007, pp. 366–68. EBSCOhost, https://doi.org/10.1016/j.bbmt.2006.11.015.

APA

Ostronoff, F., Ostronoff, M., Calixto, R., Florêncio, R., Domingues, M. C., Souto Maior, A. P., Sucupira, A., & Tagliari, C. (2007). Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 13(3), 366–368. https://doi.org/10.1016/j.bbmt.2006.11.015

Chicago

Ostronoff, Fabiana, Mauricio Ostronoff, Rodolfo Calixto, Rodrigo Florêncio, Mariana C Domingues, Ana Patricia Souto Maior, Alexandre Sucupira, and Clemente Tagliari. 2007. “Fludarabine, Cyclophosphamide, and Antithymocyte Globulin for a Patient with Dyskeratosis Congenita and Severe Bone Marrow Failure.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 13 (3): 366–68. doi:10.1016/j.bbmt.2006.11.015.